Now showing items 1-2 of 2
Remission in first-episode psychosis: Predictor variables and symptom improvement patterns
Background: Previous attempts to identify clinically useful predictors of treatment outcome in schizophrenia have been hampered by methodological inconsistencies, including a lack of standardized outcome measures. Recently ...
The effects of eicosapentaenoic acid in tardive dyskinesia: A randomized, placebo-controlled trial
Objective: Worldwide, conventional antipsychotic medication continues to be used extensively, and tardive dyskinesia (TD) remains a serious complication. The primary objective of the present study was to compare the efficacy ...